Data search
Results for MligTC455_35411
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_35411 | 583 | 12.15 | Mlig455_064235 | Neo: - Age: - |
PPP3CA | Mlig455_064235 {REF} {Length: 3595} {Human: ENSG00000138814, PPP3CA, protein phosphatase 3 catalytic subunit alpha, [Score=156, Expect=8e-46]; ENSG00000107758, PPP3CB, protein phosphatase 3 catalytic subunit beta, [Score=149, Expect=4e-43]} {Mouse: ENSMUSG00000028161, Ppp3ca, protein phosphatase 3, catalytic subunit, alpha isoform, [Score=158, Expect=1e-46]} {Dmel: FBgn0011826, Pp2B-14D, Protein phosphatase 2B at 14D, [Score=159, Expect=1e-46]} {Celegans: WBGene00006527, tax-6, Serine/threonine-protein phosphatase 2B catalytic subunit, [Score=115, Expect=1e-30]} {Smed: dd_Smed_v6_5669_1_2, dd_Smed_v6_5669_1_2, [Score=155, Expect=7e-49]} {RNA1509_42566} {RNA1310_30586} {RNA815_21103.2} |
Cumulative graph for MligTC455_35411
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 0.008 | 3.933 | 0.99690 | 1.00000 | |
| RegionR2 | 1.181 | 3.933 | 0.03248 | 0.20521 | |
| RegionR3 | -1.368 | 3.933 | 0.01361 | 0.18600 | |
| RegionR4 | -0.08 | 3.933 | 0.89958 | 1.00000 | |
| RegionR5 | 0.075 | 3.933 | 0.86121 | 1.00000 | |
| RegionR6 | -0.609 | 3.933 | 0.24289 | 0.82773 | |
| RegionR7 | -0.275 | 3.933 | 0.68135 | 1.00000 | |
| RegionR8 | 1.07 | 3.933 | 0.12283 | 0.64351 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -0.16 | 3.933 | 0.93709 | 1.00000 | |
| RegenerationR2 | 0.304 | 3.933 | 0.49110 | 0.86808 | |
| RegenerationR3 | 1.64 | 3.933 | 0.00418 | 0.11679 | |
| RegenerationR4 | 0.488 | 3.933 | 0.37815 | 0.80025 | |
| RegenerationR5 | -0.194 | 3.933 | 0.69211 | 0.94854 | |
| RegenerationR6 | 0.361 | 3.933 | 0.52741 | 0.82511 | |
| RegenerationBL | 0.365 | 3.933 | 0.54750 | 0.90439 | |
| RegenerationTP | -0.382 | 3.933 | 0.56620 | 0.94219 |
Genes with expression patterns similar to MligTC455_35411
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_35411 | 583 | 12.15 | Mlig455_064235 | Neo: - Age: - |
PPP3CA | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_064235 {REF} {Length: 3595} {Human: ENSG00000138814, PPP3CA, protein phosphatase 3 catalytic subunit alpha, [Score=156, Expect=8e-46]; ENSG00000107758, PPP3CB, protein phosphatase 3 catalytic subunit beta, [Score=149, Expect=4e-43]} {Mouse: ENSMUSG00000028161, Ppp3ca, protein phosphatase 3, catalytic subunit, alpha isoform, [Score=158, Expect=1e-46]} {Dmel: FBgn0011826, Pp2B-14D, Protein phosphatase 2B at 14D, [Score=159, Expect=1e-46]} {Celegans: WBGene00006527, tax-6, Serine/threonine-protein phosphatase 2B catalytic subunit, [Score=115, Expect=1e-30]} {Smed: dd_Smed_v6_5669_1_2, dd_Smed_v6_5669_1_2, [Score=155, Expect=7e-49]} {RNA1509_42566} {RNA1310_30586} {RNA815_21103.2} |
| 2. | MligTC455_35410 | 528 | 11 | Mlig455_064178 | Neo: - Age: Down-Down-Down Region-enriched R2: 2.241/0.03122 |
PPP3CA | 4.094 | 0.817 | 0.789 | 0.704 | 0.950 | 0.834 | - | Mlig455_064178 {REF} {Length: 4178} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=129.2]} {Human: ENSG00000138814, PPP3CA, protein phosphatase 3 catalytic subunit alpha, [Score=701, Expect=0.0]; ENSG00000107758, PPP3CB, protein phosphatase 3 catalytic subunit beta, [Score=690, Expect=0.0]; ENSG00000120910, PPP3CC, protein phosphatase 3 catalytic subunit gamma, [Score=673, Expect=0.0]} {Mouse: ENSMUSG00000028161, Ppp3ca, protein phosphatase 3, catalytic subunit, alpha isoform, [Score=703, Expect=0.0]; ENSMUSG00000021816, Ppp3cb, protein phosphatase 3, catalytic subunit, beta isoform, [Score=690, Expect=0.0]} {Dmel: FBgn0267912, CanA-14F, Calcineurin A at 14F, [Score=697, Expect=0.0]} {Celegans: WBGene00006527, tax-6, Serine/threonine-protein phosphatase 2B catalytic subunit, [Score=646, Expect=0.0]} {Smed: dd_Smed_v6_5378_0_1, dd_Smed_v6_5378_0_1, [Score=523, Expect=0.0]} {RNA1509_25279} {RNA1310_17931} {RNA815_6996} |
| 3. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
3.942 | 0.774 | - | 0.726 | 0.777 | 0.950 | 0.715 | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
| 4. | MligTC455_52003 | 1043 | 21.73 | Mlig455_050564, Mlig455_050571 | Neo: - Age: - |
RGS4, RGS8 | 3.369 | 0.792 | - | - | 0.963 | 0.900 | 0.714 | Mlig455_050564 {REF} {Length: 3240} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=116.7]} {Human: ENSG00000117152, RGS4, regulator of G protein signaling 4, [RH, Score=149, Expect=2e-42]} {Mouse: ENSMUSG00000038530, Rgs4, regulator of G-protein signaling 4, [RH, Score=153, Expect=4e-44]; ENSMUSG00000026678, Rgs5, regulator of G-protein signaling 5, [RH, Score=149, Expect=1e-42]; ENSMUSG00000042671, Rgs8, regulator of G-protein signaling 8, [RH, Score=149, Expect=1e-42]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=118, Expect=2e-30]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [Score=124, Expect=4e-33]} {Smed: dd_Smed_v6_8648_0_1, dd_Smed_v6_8648_0_1, [RH, Score=199, Expect=4e-58]} {RNA1509_11015, RNA1509_27306} {RNA1310_4876, RNA1509_11015, RNA1509_27306} {RNA1509_11015, RNA1509_27306, RNA815_6054} Mlig455_050571 {REF} {Length: 2222} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=118.3]} {Human: ENSG00000135824, RGS8, regulator of G protein signaling 8, [RH, Score=149, Expect=9e-45]; ENSG00000117152, RGS4, regulator of G protein signaling 4, [RH, Score=149, Expect=2e-44]; ENSG00000150681, RGS18, regulator of G protein signaling 18, [RH, Score=146, Expect=5e-43]; ENSG00000143248, RGS5, regulator of G protein signaling 5, [RH, Score=144, Expect=7e-43]} {Mouse: ENSMUSG00000038530, Rgs4, regulator of G-protein signaling 4, [RH, Score=153, Expect=5e-46]; ENSMUSG00000042671, Rgs8, regulator of G-protein signaling 8, [RH, Score=151, Expect=1e-45]; ENSMUSG00000026678, Rgs5, regulator of G-protein signaling 5, [RH, Score=147, Expect=7e-44]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=117, Expect=1e-31]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [Score=124, Expect=7e-35]} {Smed: dd_Smed_v6_8648_0_1, dd_Smed_v6_8648_0_1, [RH, Score=192, Expect=1e-57]} {RNA1509_27306} {RNA1310_5436.1} {RNA815_6054} |
| 5. | MligTC455_52727 | 82 | 1.72 | Mlig455_043336 | Neo: - Age: Down-Up-Down |
3.342 | 0.725 | - | 0.747 | 0.909 | 0.961 | - | Mlig455_043336 {REF} {Length: 1410} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=60.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=20.9]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=131, Expect=4e-35]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
| 6. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 3.326 | - | 0.712 | 0.727 | 0.916 | 0.971 | - | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
| 7. | MligTC455_33842 | 492 | 10.26 | Mlig455_004899 | Neo: - Age: - Region-enriched R2: 2.178/0.01972 |
CDKL1 | 3.304 | - | 0.782 | 0.791 | - | 0.950 | 0.781 | Mlig455_004899 {REF} {Length: 2500} {Pfam: Protein kinase domain [PF00069.27, score=247.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=116.6]; Haspin like kinase domain [PF12330.10, score=18.7]; ABC1 atypical kinase-like domain [PF03109.18, score=18.6]} {Human: ENSG00000100490, CDKL1, cyclin dependent kinase like 1, [RH, Score=429, Expect=3e-150]; ENSG00000205111, CDKL4, cyclin dependent kinase like 4, [RH, Score=422, Expect=2e-148]} {Mouse: ENSMUSG00000020990, Cdkl1, cyclin-dependent kinase-like 1 (CDC2-related kinase), [RH, Score=432, Expect=7e-152]; ENSMUSG00000033966, Cdkl4, cyclin-dependent kinase-like 4, [RH, Score=423, Expect=3e-148]} {Dmel: FBgn0031730, CG7236, [RH, Score=381, Expect=6e-131]} {Celegans: WBGene00012779, cdkl-1, Cyclin-Dependent Kinase-Like, [RH, Score=396, Expect=4e-136]} {Smed: dd_Smed_v6_9353_0_1, dd_Smed_v6_9353_0_1, [RH, Score=481, Expect=5e-171]} {RNA1509_19679} {RNA1310_6686.1} {RNA815_5397} |
| 8. | MligTC455_39176 | 722 | 15.04 | Mlig455_057933, Mlig455_057968 | Neo: - Age: - Region-enriched R2: 1.610/0.00268 |
IQCH | 3.298 | - | 0.792 | 0.842 | - | 0.951 | 0.713 | Mlig455_057933 {REF} {Length: 3674} {Pfam: IQ calmodulin-binding motif [PF00612.29, score=24.2]} {Human: ENSG00000103599, IQCH, IQ motif containing H, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000037801, Iqch, IQ motif containing H, [RH, Score=724, Expect=0.0]} {Smed: dd_Smed_v6_10544_0_1, dd_Smed_v6_10544_0_1, [RH, Score=691, Expect=0.0]} {RNA1310_3420} {RNA815_1553} Mlig455_057968 {REF} {Length: 3769} {Pfam: IQ calmodulin-binding motif [PF00612.29, score=24.1]} {Human: ENSG00000103599, IQCH, IQ motif containing H, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000037801, Iqch, IQ motif containing H, [RH, Score=726, Expect=0.0]} {Smed: dd_Smed_v6_10544_0_1, dd_Smed_v6_10544_0_1, [RH, Score=688, Expect=0.0]} {RNA1310_3420} {RNA815_1553} |
| 9. | MligTC455_25915 | 4499 | 93.72 | Mlig455_005297 | Neo: - Age: - Region-enriched R2: 1.495/0.00336 Regeneration-downregulated BL: -1.833 Regeneration-depleted BL: -1.833 |
CPE | 3.292 | 0.734 | - | - | 0.880 | 0.963 | 0.715 | Mlig455_005297 {REF} {Length: 3239} {Pfam: Zinc carboxypeptidase [PF00246.26, score=188.0]; Carboxypeptidase regulatory-like domain [PF13620.8, score=23.3]} {Human: ENSG00000109472, CPE, carboxypeptidase E, [Score=322, Expect=8e-105]} {Mouse: ENSMUSG00000037852, Cpe, carboxypeptidase E, [Score=318, Expect=1e-103]} {Dmel: FBgn0004648, svr, silver, [Score=225, Expect=2e-68]} {Celegans: WBGene00001189, egl-21, Carboxypeptidase E, [RH, Score=333, Expect=5e-110]} {Smed: dd_Smed_v6_3059_0_1, dd_Smed_v6_3059_0_1, [RH, Score=384, Expect=7e-130]} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1310_4621.1, RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908, RNA815_1336.1} |
| 10. | MligTC455_44352 | 997 | 20.77 | Mlig455_044946 | Neo: - |
FLOT2 | 3.168 | - | 0.715 | 0.799 | 0.701 | - | 0.953 | Mlig455_044946 {REF} {Length: 4460} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=65.0]; Flotillin [PF15975.7, score=30.6]} {Human: ENSG00000132589, FLOT2, flotillin 2, [Score=542, Expect=0.0]} {Mouse: ENSMUSG00000061981, Flot2, flotillin 2, [Score=541, Expect=0.0]} {Dmel: FBgn0264078, Flo2, Flotillin 2, [Score=543, Expect=0.0]} {Smed: dd_Smed_v6_6436_0_1, dd_Smed_v6_6436_0_1, [Score=531, Expect=0.0]} {RNA1509_20568} {RNA1310_10530, RNA1509_20568} {RNA1509_20568, RNA815_9469} |
| 11. | MligTC455_15996 | 396 | 8.26 | Mlig455_064976, Mlig455_066809 | Neo: - Age: - |
ARHGEF17 | 2.742 | - | 0.873 | - | 0.954 | 0.915 | - | Mlig455_064976 {REF} {Length: 4968} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=136.4]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [Score=233, Expect=6e-61]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [Score=239, Expect=3e-63]} {Dmel: FBgn0262562, CG43102, [RH, Score=520, Expect=4e-156]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [RH, Score=240, Expect=2e-64]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=713, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_14497} Mlig455_066809 {REF} {Length: 5061} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=125.9]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [RH, Score=266, Expect=2e-71]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [RH, Score=264, Expect=1e-70]} {Dmel: FBgn0262562, CG43102, [RH, Score=503, Expect=8e-150]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [Score=224, Expect=3e-59]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_23184} |
| 12. | MligTC455_48603 | 1006 | 20.95 | Mlig455_058556 | Neo: - Age: - Region-enriched R2: 1.380/0.01205 Regeneration-downregulated BL: -2.368 Regeneration-depleted BL: -2.368 |
CALM2 | 2.702 | 0.821 | - | - | 0.888 | 0.993 | - | Mlig455_058556 {REF} {Length: 2727} {TRANSSPLICED} {Pfam: EF-hand domain pair [PF13499.8, score=101.0]; EF hand [PF00036.34, score=97.2]; EF-hand domain pair [PF13833.8, score=81.7]; EF-hand domain [PF13405.8, score=78.5]; EF hand [PF13202.8, score=71.6]; EF-hand domain [PF14658.8, score=41.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.3]; Dockerin type I domain [PF00404.20, score=25.5]; SurA N-terminal domain [PF13624.8, score=19.1]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=132, Expect=1e-37]; ENSG00000160014, CALM3, calmodulin 3, [Score=130, Expect=5e-37]; ENSG00000198668, CALM1, calmodulin 1, [Score=130, Expect=3e-37]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=135, Expect=8e-39]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=130, Expect=3e-37]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=130, Expect=3e-37]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=127, Expect=3e-36]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=127, Expect=2e-36]} {Smed: dd_Smed_v6_12048_0_2, dd_Smed_v6_12048_0_2, [RH, Score=163, Expect=8e-49]} {RNA1509_36324, RNA1509_52694, RNA1509_5720} {RNA1310_6210.2, RNA1509_36324, RNA1509_52694, RNA1509_5720} {RNA1509_36324, RNA1509_52694, RNA1509_5720, RNA815_4293.1} |
| 13. | MligTC455_23269 | 1700 | 35.41 | Mlig455_058823 | Neo: - Age: - Region-enriched R8: 1.965/0.00066 |
SYT1 | 2.694 | - | 0.843 | - | 0.870 | 0.981 | - | Mlig455_058823 {REF} {Length: 3328} {Pfam: C2 domain [PF00168.32, score=181.3]; CEP76 C2 domain [PF15627.8, score=21.0]; Phosphoinositide 3-kinase C2 [PF00792.26, score=20.4]} {Human: ENSG00000067715, SYT1, synaptotagmin 1, [RH, Score=436, Expect=4e-151]} {Mouse: ENSMUSG00000035864, Syt1, synaptotagmin I, [RH, Score=435, Expect=4e-151]} {Dmel: FBgn0004242, Syt1, Synaptotagmin 1, [Score=496, Expect=1e-174]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=432, Expect=6e-150]} {Smed: dd_Smed_v6_6730_0_1, dd_Smed_v6_6730_0_1, [Score=542, Expect=0.0]} {RNA1509_10517, RNA1509_25740, RNA1509_36281, RNA1509_40080} {RNA1310_21689, RNA1509_10517, RNA1509_25740, RNA1509_36281, RNA1509_40080} {RNA1509_10517, RNA1509_25740, RNA1509_36281, RNA1509_40080, RNA815_10622.1} |
| 14. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 2.603 | - | 0.712 | - | 0.920 | 0.971 | - | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
| 15. | MligTC455_53413 | 249 | 5.2 | Mlig455_035022 | Neo: - Age: - Region-specific R2: 4.451 Region-enriched R2: 3.023/0.00460 |
RP1 | 2.603 | - | 0.713 | - | 0.932 | 0.958 | - | Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1} |
| 16. | MligTC455_49620 | 290 | 6.04 | Mlig455_001138, Mlig455_001300 | Neo: - Age: - Region-enriched R2: 5.198/0.00000 |
ELAVL3, ELAVL4 | 2.601 | - | - | - | 0.850 | 0.976 | 0.775 | Mlig455_001138 {REF} {Length: 3131} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=206.7]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=37.5]; Occluded RNA-recognition motif [PF16842.7, score=27.0]} {Human: ENSG00000162374, ELAVL4, ELAV like RNA binding protein 4, [Score=268, Expect=6e-85]; ENSG00000196361, ELAVL3, ELAV like RNA binding protein 3, [Score=268, Expect=3e-85]; ENSG00000107105, ELAVL2, ELAV like RNA binding protein 2, [Score=268, Expect=2e-84]} {Mouse: ENSMUSG00000003410, Elavl3, ELAV like RNA binding protein 3, [RH, Score=270, Expect=2e-87]} {Dmel: FBgn0010263, Rbp9, RNA-binding protein 9, [Score=273, Expect=2e-86]} {Celegans: WBGene00001368, exc-7, [RH, Score=327, Expect=6e-107]} {Smed: dd_Smed_v6_13151_0_1, dd_Smed_v6_13151_0_1, [RH, Score=269, Expect=8e-84]} {RNA1509_28072} {RNA1310_22289} {RNA815_15133} Mlig455_001300 {REF} {Length: 3150} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=203.6]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=36.4]; Occluded RNA-recognition motif [PF16842.7, score=27.0]} {Human: ENSG00000196361, ELAVL3, ELAV like RNA binding protein 3, [Score=274, Expect=4e-87]; ENSG00000162374, ELAVL4, ELAV like RNA binding protein 4, [Score=271, Expect=6e-86]; ENSG00000107105, ELAVL2, ELAV like RNA binding protein 2, [Score=268, Expect=3e-85]; ENSG00000066044, ELAVL1, ELAV like RNA binding protein 1, [Score=262, Expect=3e-83]} {Mouse: ENSMUSG00000003410, Elavl3, ELAV like RNA binding protein 3, [RH, Score=271, Expect=7e-88]} {Dmel: FBgn0010263, Rbp9, RNA-binding protein 9, [Score=270, Expect=4e-85]} {Celegans: WBGene00001368, exc-7, [RH, Score=326, Expect=1e-106]} {Smed: dd_Smed_v6_11311_0_2, dd_Smed_v6_11311_0_2, [RH, Score=300, Expect=2e-97]} {RNA1509_28072} {RNA1310_22289} {RNA815_15133} |
| 17. | MligTC455_52238 | 282 | 5.87 | Mlig455_029211 | Neo: - Age: logFC(26M/2M)=-0.312 |
ABCG2 | 2.577 | - | - | - | 0.960 | 0.869 | 0.748 | Mlig455_029211 {REF} {Length: 3240} {Human: ENSG00000118777, ABCG2, ATP binding cassette subfamily G member 2 (Junior blood group), [Score=80.5, Expect=3e-15]} {Mouse: ENSMUSG00000029802, Abcg2, ATP binding cassette subfamily G member 2 (Junior blood group), [Score=79.0, Expect=7e-15]} {Smed: dd_Smed_v6_4225_0_1, dd_Smed_v6_4225_0_1, [Score=108, Expect=2e-24]} {RNA1509_38878} {RNA1310_949.2} {RNA815_1895} |
| 18. | MligTC455_50601 | 21 | 0.44 | Mlig455_018462 | Neo: - Age: - |
2.567 | - | 0.730 | - | 0.884 | 0.953 | - | Mlig455_018462 {REF} {Length: 2878} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=164.0]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=117, Expect=1e-27]} {RNA1310_8235} {RNA815_10456.1} | |
| 19. | MligTC455_29201 | 1280 | 26.67 | Mlig455_049817 | Neo: - Age: - Regeneration-downregulated BL: -1.729 Regeneration-depleted BL: -1.729 |
OTOF | 2.566 | - | - | - | 0.879 | 0.959 | 0.728 | Mlig455_049817 {REF} {Length: 7973} {Pfam: C2 domain [PF00168.32, score=225.3]; FerB (NUC096) domain [PF08150.14, score=99.1]; Ferlin C-terminus [PF16165.7, score=97.7]; FerI (NUC094) domain [PF08151.14, score=61.5]} {Human: ENSG00000115155, OTOF, otoferlin, [RH, Score=910, Expect=0.0]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [RH, Score=915, Expect=0.0]} {Dmel: FBgn0266757, mfr, misfire, [RH, Score=301, Expect=4e-84]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=150, Expect=9e-36]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=1476, Expect=0.0]} {RNA1509_5256} {RNA1310_1416.2} {RNA815_411.1} |
| 20. | MligTC455_49296 | 69 | 1.44 | Mlig455_034352, Mlig455_034414 | Neo: - Age: - |
2.566 | - | - | 0.770 | 0.824 | 0.972 | - | Mlig455_034352 {REF} {Length: 912} {TRANSSPLICED} Mlig455_034414 {REF} {Length: 919} {TRANSSPLICED} |
|
| 21. | MligTC455_09313 | 673 | 14.01 | Mlig455_021865, Mlig455_021943 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.967/0.00176 |
2.563 | - | - | 0.767 | 0.817 | 0.979 | - | Mlig455_021865 {REF} {Length: 5096} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [Score=79.3, Expect=1e-14]} {RNA1509_22941} {RNA1310_4839.1} {RNA815_8984} Mlig455_021943 {REF} {Length: 5863} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [RH, Score=83.6, Expect=7e-16]} {RNA1509_22941} {RNA1310_4839.1, RNA1509_22941} {RNA1509_22941, RNA815_15728} |
|
| 22. | MligTC455_45191 | 1420 | 29.58 | Mlig455_000192, Mlig455_058450, Mlig455_067701 | Neo: - Age: - Regeneration-downregulated BL: -2.403 Regeneration-depleted BL: -2.403 |
BSG | 2.554 | 0.791 | - | - | 0.793 | 0.970 | - | Mlig455_000192 {REF} {Length: 2540} {Pfam: Immunoglobulin domain [PF13927.8, score=57.1]; Immunoglobulin I-set domain [PF07679.18, score=53.6]; Immunoglobulin domain [PF00047.27, score=36.0]; Immunoglobulin domain [PF13895.8, score=30.4]; Immunoglobulin V-set domain [PF07686.19, score=22.2]} {Human: ENSG00000172270, BSG, basigin (Ok blood group), [Score=67.8, Expect=1e-12]} {Mouse: ENSMUSG00000023175, Bsg, basigin, [Score=82.4, Expect=3e-17]} {Dmel: FBgn0261822, Bsg, Basigin, [RH, Score=61.6, Expect=1e-10]} {Celegans: WBGene00004729, sax-3, [Score=57.4, Expect=6e-09]} {Smed: dd_Smed_v6_1827_0_1, dd_Smed_v6_1827_0_1, [Score=81.6, Expect=9e-18]} {RNA1509_31454, RNA1509_47270} {RNA1310_8812, RNA1509_31454, RNA1509_47270} {RNA1509_31454, RNA1509_47270, RNA815_2422} Mlig455_058450 {REF} {Length: 3207} {Pfam: Immunoglobulin domain [PF13927.8, score=56.4]; Immunoglobulin I-set domain [PF07679.18, score=53.0]; Immunoglobulin domain [PF00047.27, score=36.1]; Immunoglobulin domain [PF13895.8, score=29.3]; Immunoglobulin V-set domain [PF07686.19, score=22.0]} {Human: ENSG00000172270, BSG, basigin (Ok blood group), [Score=67.4, Expect=2e-12]} {Mouse: ENSMUSG00000023175, Bsg, basigin, [Score=81.6, Expect=6e-17]} {Dmel: FBgn0261822, Bsg, Basigin, [RH, Score=62.4, Expect=6e-11]} {Celegans: WBGene00004729, sax-3, [Score=58.5, Expect=3e-09]} {Smed: dd_Smed_v6_1827_0_1, dd_Smed_v6_1827_0_1, [Score=80.5, Expect=3e-17]} {RNA1509_31454} {RNA1310_8812} {RNA815_2422} Mlig455_067701 {REF} {Length: 2864} {Celegans: WBGene00018026, F35A5.4, [Score=60.1, Expect=8e-11]} {RNA1509_47270} {RNA1310_8812} {RNA815_2422} |
| 23. | MligTC455_47704 | 106 | 2.21 | Mlig455_032247 | Neo: - |
WSCD2 | 2.554 | - | - | - | 0.883 | 0.956 | 0.715 | Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780} |
| 24. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
2.551 | - | - | - | 0.836 | 0.961 | 0.754 | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
| 25. | MligTC455_44999 | 2214 | 46.12 | Mlig455_067394, Mlig455_069538 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.840/0.00027 |
2.551 | - | - | - | 0.800 | 0.963 | 0.788 | Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1} Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1} |
|
| 26. | MligTC455_45135 | 20518 | 427.46 | Mlig455_055032, Mlig455_055049 | Neo: - Age: - Region-enriched R2: 1.186/0.02756 Regeneration-downregulated BL: -2.004 Regeneration-depleted BL: -2.004 |
PAM | 2.55 | - | - | - | 0.850 | 0.958 | 0.742 | Mlig455_055032 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.5]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.9]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=205, Expect=4e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=232, Expect=1e-72]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_979} {RNA1310_15063.1} {RNA815_4981} Mlig455_055049 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.4]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.8]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=205, Expect=3e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=5e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=233, Expect=5e-73]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_32895, RNA1509_979} {RNA1310_15063.1, RNA1509_32895, RNA1509_979} {RNA1509_32895, RNA1509_979, RNA815_4981} |
| 27. | MligTC455_45134 | 9943 | 207.14 | Mlig455_022505 | Neo: - Age: - Region-enriched R2: 1.329/0.00560 Regeneration-downregulated BL: -1.932 Regeneration-depleted BL: -1.932 |
PAM | 2.543 | - | - | - | 0.854 | 0.957 | 0.732 | Mlig455_022505 {REF} {Length: 1757} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=107.0]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=69.2]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=190, Expect=4e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=186, Expect=7e-53]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [Score=219, Expect=5e-69]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [Score=224, Expect=8e-72]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [Score=255, Expect=4e-83]} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1310_15063.1, RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118, RNA815_4981} |
| 28. | MligTC455_24064 | 359 | 7.48 | Mlig455_048183 | Neo: - Age: - |
SNAP25 | 2.533 | - | - | 0.768 | 0.796 | 0.969 | - | Mlig455_048183 {REF} {Length: 1315} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_8624} {RNA1310_24253} {RNA815_10439} |
| 29. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 2.521 | - | - | 0.708 | 0.837 | 0.976 | - | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
| 30. | MligTC455_29202 | 397 | 8.26 | Mlig455_016520 | Neo: - Age: Up-Down-Up |
OTOF | 2.509 | - | - | - | 0.812 | 0.964 | 0.733 | Mlig455_016520 {REF} {Length: 3035} {Pfam: C2 domain [PF00168.32, score=46.4]} {Human: ENSG00000115155, OTOF, otoferlin, [Score=310, Expect=3e-90]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [Score=302, Expect=6e-88]} {Dmel: FBgn0266757, mfr, misfire, [Score=131, Expect=1e-31]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=73.6, Expect=4e-13]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=452, Expect=6e-140]} {RNA1509_5256} {RNA1310_1035} {RNA815_411.1} |
| 31. | MligTC455_41823 | 300 | 6.25 | Mlig455_022277 | Neo: - Age: - Region-enriched R2: 3.150/0.00185 |
2.501 | - | - | 0.779 | 0.757 | 0.965 | - | Mlig455_022277 {REF} {Length: 753} {RNA1509_49797} {RNA1310_60350} {RNA815_30999} | |
| 32. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
2.5 | - | - | - | 0.804 | 0.972 | 0.724 | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
| 33. | MligTC455_29200 | 404 | 8.42 | Mlig455_016456 | Neo: - Age: - |
OTOF | 2.499 | - | - | - | 0.807 | 0.961 | 0.731 | Mlig455_016456 {REF} {Length: 7086} {TRANSSPLICED} {Pfam: C2 domain [PF00168.32, score=232.5]; Ferlin C-terminus [PF16165.7, score=97.7]; FerB (NUC096) domain [PF08150.14, score=96.8]; FerI (NUC094) domain [PF08151.14, score=61.5]} {Human: ENSG00000115155, OTOF, otoferlin, [RH, Score=921, Expect=0.0]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [RH, Score=925, Expect=0.0]} {Dmel: FBgn0266757, mfr, misfire, [Score=308, Expect=5e-90]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=151, Expect=5e-36]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=1470, Expect=0.0]} {RNA1509_51560} {RNA1310_1416.6} {RNA815_411.1} |
| 34. | MligTC455_04162 | 131 | 2.73 | Mlig455_028924 | Neo: - |
HMCN1 | 2.489 | - | 0.718 | - | 0.821 | 0.950 | - | Mlig455_028924 {REF} {Length: 3929} {Pfam: Immunoglobulin domain [PF13927.8, score=144.9]; Immunoglobulin I-set domain [PF07679.18, score=119.8]; Immunoglobulin domain [PF13895.8, score=113.4]; Immunoglobulin domain [PF00047.27, score=102.3]; Immunoglobulin V-set domain [PF07686.19, score=36.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=35.3]; Immunoglobulin C1-set domain [PF07654.17, score=23.3]; C17orf99 Ig domain [PF17736.3, score=20.9]; Immunoglobulin domain [PF18452.3, score=19.8]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=103, Expect=2e-21]; ENSG00000148357, HMCN2, hemicentin 2, [Score=100, Expect=8e-21]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=107, Expect=5e-23]; ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=103, Expect=7e-22]} {Dmel: FBgn0000547, ed, echinoid, [Score=147, Expect=2e-35]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=100, Expect=3e-21]} {Smed: dd_Smed_v6_13903_0_1, dd_Smed_v6_13903_0_1, [Score=162, Expect=2e-40]} {RNA1310_26618} {RNA815_41641} |
| 35. | MligTC455_51779 | 660 | 13.75 | Mlig455_031396 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.441/0.00016 |
CACNA1C | 2.469 | 0.756 | - | - | - | 0.958 | 0.755 | Mlig455_031396 {REF} {Length: 8157} {Pfam: Ion transport protein [PF00520.33, score=797.6]; Voltage gated calcium channel IQ domain [PF08763.13, score=101.0]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=100.3]; Polycystin cation channel [PF08016.14, score=31.5]} {Human: ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1289, Expect=0.0]; ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1289, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=1286, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=1273, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=1294, Expect=0.0]; ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=1288, Expect=0.0]; ENSMUSG00000031142, Cacna1f, calcium channel, voltage-dependent, alpha 1F subunit, [Score=1276, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [Score=1260, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=1292, Expect=0.0]} {Celegans: WBGene00006742, unc-2, High voltage activated calcium channel alpha-1 subunit, [RH, Score=1690, Expect=0.0]} {Smed: dd_Smed_v6_13295_0_1, dd_Smed_v6_13295_0_1, [RH, Score=2129, Expect=0.0]} {RNA1509_11510} {RNA1310_2184.1} {RNA815_2606} |
| 36. | MligTC455_27673 | 123 | 2.56 | Mlig455_041241, Mlig455_053095 | Neo: - Age: Up-Down-Up |
GLRA1, GLRA3 | 2.455 | - | 0.757 | - | 0.719 | 0.979 | - | Mlig455_041241 {REF} {Length: 4857} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=165.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.7]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=253, Expect=3e-78]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=9e-77]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=246, Expect=1e-75]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=246, Expect=7e-76]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=244, Expect=2e-74]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=243, Expect=1e-74]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=240, Expect=2e-73]} {Dmel: FBgn0024963, GluClalpha, [Score=256, Expect=1e-79]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [RH, Score=247, Expect=6e-76]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=440, Expect=1e-151]} {RNA1509_35986} {RNA1310_28655} {RNA815_20247} Mlig455_053095 {REF} {Length: 4892} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=163.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=83.4]} {Human: ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=254, Expect=9e-79]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=251, Expect=1e-77]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=243, Expect=9e-75]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=9e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=244, Expect=5e-75]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=242, Expect=4e-74]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=236, Expect=2e-72]} {Dmel: FBgn0024963, GluClalpha, [Score=257, Expect=4e-80]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=252, Expect=3e-78]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=449, Expect=1e-155]} {RNA1509_54479} {RNA1310_56579} {RNA815_20247} |
| 37. | MligTC455_49593 | 323 | 6.72 | Mlig455_025219 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.432/0.00265 |
RRBP1 | 2.452 | - | - | 0.757 | 0.730 | 0.965 | - | Mlig455_025219 {REF} {Length: 1413} {Human: ENSG00000125844, RRBP1, ribosome binding protein 1, [RH, Score=62.8, Expect=2e-11]} {RNA1509_39523} {RNA1310_52655} {RNA815_22785} |
| 38. | MligTC455_46323 | 447 | 9.3 | Mlig455_007788 | Neo: - Age: logFC(26M/2M)=-0.548 |
PAM | 2.437 | - | 0.775 | - | 0.959 | - | 0.703 | Mlig455_007788 {REF} {Length: 3954} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=52.8]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=51.4]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=101, Expect=2e-22]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=99.8, Expect=5e-22]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [Score=107, Expect=2e-25]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [Score=89.0, Expect=2e-19]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [Score=119, Expect=8e-30]} {RNA1509_54159} {RNA1310_19370} {RNA815_7199} |
| 39. | MligTC455_16739 | 628 | 13.08 | Mlig455_040111 | Neo: - Age: logFC(26M/2M)=-0.328 Region-enriched R2: 3.456/0.01732 Regeneration-downregulated R5: -4.251 Regeneration-depleted R5: -4.251 |
PCSK1 | 2.435 | - | - | - | 0.950 | 0.770 | 0.715 | Mlig455_040111 {REF} {Length: 2929} {Pfam: Subtilase family [PF00082.24, score=160.6]; Proprotein convertase P-domain [PF01483.22, score=87.0]; Peptidase S8 pro-domain [PF16470.7, score=50.0]} {Human: ENSG00000175426, PCSK1, proprotein convertase subtilisin/kexin type 1, [RH, Score=550, Expect=0.0]} {Mouse: ENSMUSG00000021587, Pcsk1, proprotein convertase subtilisin/kexin type 1, [RH, Score=550, Expect=0.0]} {Dmel: FBgn0004598, Fur2, Furin 2, [Score=483, Expect=1e-152]} {Celegans: WBGene00002232, kpc-1, Furin-like protease kpc-1, [Score=468, Expect=3e-156]} {Smed: dd_Smed_v6_8406_0_1, dd_Smed_v6_8406_0_1, [RH, Score=474, Expect=2e-159]} {RNA1509_20395} {RNA1310_6257} {RNA815_2270.1} |
| 40. | MligTC455_45020 | 386 | 8.05 | Mlig455_012422 | Neo: - Age: - Region-enriched R2: 4.067/0.00066 |
AVP | 2.429 | - | - | - | 0.755 | 0.963 | 0.711 | Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813} |
| 41. | MligTC455_51536 | 78 | 1.62 | Mlig455_040699 | Neo: - Age: - |
2.429 | - | - | 0.736 | 0.732 | 0.961 | - | Mlig455_040699 {REF} {Length: 2015} {RNA1310_34295.1} {RNA815_22630} | |
| 42. | MligTC455_14829 | 56 | 1.17 | Mlig455_053237 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.599 Region-enriched R2: 3.828/0.03404 |
SSUH2 | 2.423 | - | - | 0.735 | - | 0.965 | 0.723 | Mlig455_053237 {REF} {Length: 1420} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=156, Expect=2e-43]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=117, Expect=2e-29]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=87.4, Expect=9e-19]} {RNA1509_46058} {RNA1310_5028.1} {RNA815_5650} |
| 43. | MligTC455_52199 | 1032 | 21.49 | Mlig455_031255, Mlig455_031301 | Neo: - Age: Down-Down-Up |
2.416 | - | - | 0.705 | - | 0.965 | 0.746 | Mlig455_031255 {REF} {Length: 1896} {Pfam: Innexin [PF00876.20, score=210.3]} {Celegans: WBGene00002127, inx-5, Innexin-5, [Score=134, Expect=1e-34]} {Smed: dd_Smed_v6_734_0_1, dd_Smed_v6_734_0_1, [Score=139, Expect=1e-36]} {RNA1509_2324} {RNA1310_13247} {RNA815_6165.1} Mlig455_031301 {REF} {Length: 2187} {Pfam: Innexin [PF00876.20, score=210.3]} {Celegans: WBGene00002127, inx-5, Innexin-5, [Score=134, Expect=1e-34]} {Smed: dd_Smed_v6_734_0_1, dd_Smed_v6_734_0_1, [Score=139, Expect=2e-36]} {RNA1509_2324} {RNA1310_13247} {RNA815_6165.1} |
|
| 44. | MligTC455_08774 | 25 | 0.53 | Mlig455_001889 | Neo: - Age: Up-Down-Down |
HCRTR2 | 2.402 | 0.714 | - | 0.733 | - | 0.955 | - | Mlig455_001889 {REF} {Length: 3436} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=160.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=24.1]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=215, Expect=2e-63]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [RH, Score=212, Expect=1e-62]} {Dmel: FBgn0038874, ETHR, [Score=142, Expect=6e-37]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=116, Expect=6e-28]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=202, Expect=1e-59]} {RNA1310_31833} {RNA815_15909} |
| 45. | MligTC455_39747 | 9244 | 192.57 | Mlig455_062337 | Neo: - |
1.893 | - | - | - | 0.934 | 0.959 | - | Mlig455_062337 {REF} {Length: 1172} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=60.1, Expect=9e-11]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [RH, Score=47.4, Expect=2e-07]} {RNA1509_16548, RNA1509_58675} {RNA1310_55834.1, RNA1509_58675} {RNA1509_58675, RNA815_29732} | |
| 46. | MligTC455_19040 | 49 | 1.03 | Mlig455_003437 | Neo: - Age: - Region-enriched R2: 6.133/0.00615 |
CAV1 | 1.881 | - | - | - | 0.899 | 0.982 | - | Mlig455_003437 {REF} {Length: 808} {Pfam: Caveolin [PF01146.19, score=118.3]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=101, Expect=7e-28]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=102, Expect=2e-28]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.6, Expect=9e-17]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=142, Expect=8e-45]} {RNA1509_53381} {RNA1310_97043} {RNA815_32565} |
| 47. | MligTC455_45414 | 4030 | 83.95 | Mlig455_045096 | Neo: - Age: Down-Down-Up Region-specific R2: 2.245 Region-enriched R2: 1.386/0.00025 Regeneration-depleted TP: -1.938 |
1.84 | - | - | - | 0.890 | 0.950 | - | Mlig455_045096 {REF} {Length: 1427} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1310_24092, RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192, RNA815_369.1} | |
| 48. | MligTC455_12992 | 102 | 2.12 | Mlig455_034920 | Neo: - Age: - Region-enriched R2: 3.155/0.02568 |
RAC2 | 1.839 | - | - | - | 0.860 | 0.979 | - | Mlig455_034920 {REF} {Length: 3245} {Pfam: Ras family [PF00071.24, score=175.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=80.0]; ADP-ribosylation factor family [PF00025.23, score=32.7]} {Human: ENSG00000128340, RAC2, Rac family small GTPase 2, [Score=277, Expect=1e-95]; ENSG00000136238, RAC1, Rac family small GTPase 1, [Score=273, Expect=6e-94]} {Mouse: ENSMUSG00000033220, Rac2, Rac family small GTPase 2, [Score=275, Expect=3e-95]; ENSMUSG00000001847, Rac1, Rac family small GTPase 1, [Score=273, Expect=4e-94]; ENSMUSG00000018012, Rac3, Rac family small GTPase 3, [Score=263, Expect=3e-90]} {Dmel: FBgn0010333, Rac1, [Score=270, Expect=2e-93]} {Celegans: WBGene00000424, ced-10, Ras-related protein ced-10, [Score=268, Expect=2e-92]} {Smed: dd_Smed_v6_610_0_1, dd_Smed_v6_610_0_1, [Score=251, Expect=4e-86]} {RNA1509_26483} {RNA1310_31644} {RNA815_16762} |
| 49. | MligTC455_35019 | 168 | 3.49 | Mlig455_046994 | Neo: - Age: - |
ASIC4 | 1.839 | - | - | - | 0.953 | 0.886 | - | Mlig455_046994 {REF} {Length: 4001} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=76.3, Expect=1e-13]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=76.3, Expect=8e-14]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=72.8, Expect=8e-13]} {Smed: dd_Smed_v6_15233_0_1, dd_Smed_v6_15233_0_1, [RH, Score=103, Expect=1e-22]} {RNA1509_33816} {RNA1310_3176, RNA1509_33816} {RNA1509_33816, RNA815_12439} |
| 50. | MligTC455_16866 | 18 | 0.37 | Mlig455_065296 | Neo: - Age: - |
1.835 | - | - | - | 0.859 | 0.976 | - | Mlig455_065296 {REF} {Length: 1827} {RNA1310_92472} | |
| 51. | MligTC455_16867 | 18 | 0.37 | Mlig455_065319 | Neo: - Age: - |
1.835 | - | - | - | 0.859 | 0.976 | - | Mlig455_065319 {REF} {Length: 1743} {RNA1310_92472} | |
| 52. | MligTC455_25914 | 4684 | 97.58 | Mlig455_004975 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.418 Region-enriched R2: 1.471/0.00163 Regeneration-downregulated BL: -1.843 Regeneration-depleted BL: -1.843 |
1.833 | - | - | - | 0.872 | 0.961 | - | Mlig455_004975 {REF} {Length: 5220} {RNA1509_1158, RNA1509_11723} {RNA1310_4621.1, RNA1509_11723} {RNA1509_11723, RNA815_1336.1} | |
| 53. | MligTC455_19578 | 23 | 0.47 | Mlig455_018093, Mlig455_059526 | Neo: - Age: - |
1.829 | - | - | - | 0.869 | 0.960 | - | Mlig455_018093 {REF} {Length: 2450} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=99.2]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=72.4, Expect=4e-13]} {RNA1310_65251} Mlig455_059526 {REF} {Length: 2621} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=74.7, Expect=8e-14]} {RNA1310_65251} |
|
| 54. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 1.827 | - | - | - | 0.860 | 0.967 | - | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
| 55. | MligTC455_46793 | 652 | 13.58 | Mlig455_058553 | Neo: - Age: - |
SYTL4 | 1.826 | - | - | - | 0.840 | 0.986 | - | Mlig455_058553 {REF} {Length: 2601} {TRANSSPLICED} {Pfam: C2 domain [PF00168.32, score=103.1]} {Human: ENSG00000102362, SYTL4, synaptotagmin like 4, [Score=153, Expect=2e-38]; ENSG00000147041, SYTL5, synaptotagmin like 5, [Score=150, Expect=2e-37]; ENSG00000142765, SYTL1, synaptotagmin like 1, [Score=149, Expect=1e-37]} {Mouse: ENSMUSG00000031255, Sytl4, synaptotagmin-like 4, [Score=160, Expect=6e-41]} {Dmel: FBgn0266756, btsz, bitesize, [Score=193, Expect=2e-51]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=86.3, Expect=1e-17]} {Smed: dd_Smed_v6_10375_0_1, dd_Smed_v6_10375_0_1, [RH, Score=157, Expect=3e-40]} {RNA1509_50455} {RNA1310_5507.1, RNA1509_50455} {RNA1509_50455, RNA815_17811} |
| 56. | MligTC455_17018 | 93 | 1.93 | Mlig455_008015 | Neo: - Age: logFC(26M/2M)=1.300 |
1.822 | - | - | - | 0.859 | 0.963 | - | Mlig455_008015 {REF} {Length: 1919} {TRANSSPLICED} {Pfam: Sleepless protein [PF17064.7, score=37.0]} {Dmel: FBgn0260499, qvr, quiver, [Score=69.7, Expect=2e-15]} {Smed: dd_Smed_v6_16907_0_2, dd_Smed_v6_16907_0_2, [Score=74.7, Expect=1e-17]} {RNA1310_61248} {RNA815_27518} | |
| 57. | MligTC455_39748 | 17060 | 355.41 | Mlig455_068905 | Neo: - Age: - Region-enriched R7: 2.255/0.00030 Regeneration-downregulated BL: -3.088 Regeneration-depleted BL: -3.088 |
1.819 | - | - | - | 0.861 | 0.958 | - | Mlig455_068905 {REF} {Length: 1123} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=52.4, Expect=4e-08]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [RH, Score=47.4, Expect=2e-07]} {RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549} {RNA1310_55834.1, RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549} {RNA1509_13775, RNA1509_15073, RNA1509_16548, RNA1509_23529, RNA1509_549, RNA815_29732} | |
| 58. | MligTC455_47806 | 2724 | 56.76 | Mlig455_033677 | Neo: - Age: - Region-specific R2: 3.773 Region-enriched R2: 2.504/0.00005 |
1.817 | - | - | - | 0.855 | 0.962 | - | Mlig455_033677 {REF} {Length: 1836} {RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504} {RNA1310_30659.1, RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504} {RNA1509_1605, RNA1509_16422, RNA1509_33244, RNA1509_46504, RNA815_13807} | |
| 59. | MligTC455_26092 | 67 | 1.39 | Mlig455_048489 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.677 Region-enriched R2: 4.303/0.01110 |
1.808 | - | - | - | 0.849 | 0.959 | - | Mlig455_048489 {REF} {Length: 2319} {Pfam: Lectin C-type domain [PF00059.23, score=23.3]} {RNA1509_25383} {RNA1310_27113} {RNA815_24719} | |
| 60. | MligTC455_47807 | 2664 | 55.5 | Mlig455_050143 | Neo: - Age: - Region-specific R2: 3.807 Region-enriched R2: 2.561/0.00001 |
1.808 | - | - | - | 0.848 | 0.960 | - | Mlig455_050143 {REF} {Length: 1560} {RNA1509_1605, RNA1509_28756} {RNA1310_30659.1, RNA1509_28756} {RNA1509_28756, RNA815_13807} | |
| 61. | MligTC455_12032 | 92 | 1.91 | Mlig455_044477 | Neo: - Age: - |
KCNIP1 | 1.806 | - | - | - | 0.851 | 0.955 | - | Mlig455_044477 {REF} {Length: 1077} {Pfam: EF hand [PF00036.34, score=60.1]; EF-hand domain [PF13405.8, score=57.2]; EF-hand domain pair [PF13499.8, score=54.7]; EF-hand domain pair [PF13833.8, score=47.2]; EF hand [PF13202.8, score=43.0]} {Human: ENSG00000182132, KCNIP1, potassium voltage-gated channel interacting protein 1, [Score=169, Expect=9e-52]; ENSG00000120049, KCNIP2, potassium voltage-gated channel interacting protein 2, [Score=164, Expect=7e-49]} {Mouse: ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=170, Expect=2e-52]} {Dmel: FBgn0039380, CG5890, [Score=150, Expect=5e-45]} {Celegans: WBGene00008998, ncs-4, Neuronal Calcium Sensor family, [RH, Score=121, Expect=1e-33]} {Smed: dd_Smed_v6_9727_0_1, dd_Smed_v6_9727_0_1, [Score=163, Expect=6e-50]} {RNA1310_40826} {RNA815_29104} |
| 62. | MligTC455_37683 | 97 | 2.03 | Mlig455_027754 | Neo: - Age: - |
KCNN2 | 1.8 | - | - | - | 0.839 | 0.961 | - | Mlig455_027754 {REF} {Length: 1617} {Pfam: Calmodulin binding domain [PF02888.18, score=117.1]; Ion channel [PF07885.18, score=49.9]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=359, Expect=1e-120]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=353, Expect=1e-120]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=343, Expect=4e-115]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=358, Expect=1e-120]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=353, Expect=2e-116]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=343, Expect=5e-115]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=343, Expect=5e-115]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=400, Expect=1e-137]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=303, Expect=2e-98]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [Score=355, Expect=1e-118]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_9828.1} |
| 63. | MligTC455_16166 | 638 | 13.28 | Mlig455_045546, Mlig455_052637 | Neo: - Age: - |
B3GALT5 | 1.798 | - | - | - | 0.847 | 0.951 | - | Mlig455_045546 {REF} {Length: 2520} {Pfam: Galactosyltransferase [PF01762.23, score=159.0]} {Human: ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [RH, Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=113, Expect=5e-27]; ENSMUSG00000074892, B3galt5, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5, [Score=111, Expect=2e-26]; ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=110, Expect=1e-25]} {Dmel: FBgn0035558, CG11357, [RH, Score=147, Expect=3e-38]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=72.8, Expect=3e-14]} {Smed: dd_Smed_v6_12783_0_1, dd_Smed_v6_12783_0_1, [Score=149, Expect=5e-40]} {RNA1509_45540} {RNA1310_2435} {RNA815_25407} Mlig455_052637 {REF} {Length: 2225} {Pfam: Galactosyltransferase [PF01762.23, score=159.1]} {Human: ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [RH, Score=125, Expect=3e-31]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=114, Expect=1e-27]; ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=109, Expect=3e-25]} {Dmel: FBgn0035558, CG11357, [Score=143, Expect=1e-36]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=71.2, Expect=3e-13]} {Smed: dd_Smed_v6_12783_0_1, dd_Smed_v6_12783_0_1, [Score=152, Expect=3e-41]} {RNA1509_45540} {RNA1310_2435} {RNA815_25407} |
| 64. | MligTC455_46582 | 6815 | 141.97 | Mlig455_027253, Mlig455_027264 | Neo: - Age: - Region-enriched R8: 2.137/0.00000 Regeneration-downregulated TP: -1.999 Regeneration-depleted TP: -1.999 |
1.794 | - | - | - | 0.831 | 0.963 | - | Mlig455_027253 {REF} {Length: 2256} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=25.3]} {Dmel: FBgn0051221, CG31221, [Score=63.2, Expect=5e-12]} {Celegans: WBGene00010290, F58H1.7, [RH, Score=66.6, Expect=1e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=173, Expect=3e-55]} {RNA1509_59060} {RNA1310_28256} {RNA815_15141.1} Mlig455_027264 {REF} {Length: 973} {Dmel: FBgn0051221, CG31221, [Score=53.5, Expect=1e-08]} {Celegans: WBGene00010290, F58H1.7, [Score=50.4, Expect=7e-08]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [Score=147, Expect=5e-45]} {RNA1509_59060} {RNA1310_28256} {RNA815_15141.1} |
|
| 65. | MligTC455_49862 | 26 | 0.54 | Mlig455_019435 | Neo: - Age: - |
SHOX2 | 1.793 | - | - | - | 0.836 | 0.957 | - | Mlig455_019435 {REF} {Length: 904} {Pfam: Homeodomain [PF00046.31, score=84.8]; Homeobox KN domain [PF05920.13, score=23.6]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=89.0, Expect=4e-22]; ENSG00000185960, SHOX, short stature homeobox, [Score=87.0, Expect=5e-21]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=89.0, Expect=3e-22]} {Dmel: FBgn0085396, CG34367, [Score=89.7, Expect=9e-22]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=83.6, Expect=5e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=86.3, Expect=2e-20]} {RNA1310_51707} {RNA815_41055} |
| 66. | MligTC455_54204 | 344 | 7.17 | Mlig455_006398 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=0.351 Region-specific R2: 5.395 Region-enriched R2: 4.187/0.01201 |
MYH6 | 1.788 | 0.813 | - | - | - | 0.975 | - | Mlig455_006398 {REF} {Length: 7465} {Pfam: Myosin head (motor domain) [PF00063.23, score=927.6]; Myosin tail [PF01576.21, score=593.3]; Myosin N-terminal SH3-like domain [PF02736.21, score=60.7]; Crescentin protein [PF19220.2, score=26.4]; Macoilin family [PF09726.11, score=19.0]} {Human: ENSG00000197616, MYH6, myosin heavy chain 6, [RH, Score=2074, Expect=0.0]; ENSG00000092054, MYH7, myosin heavy chain 7, [RH, Score=2064, Expect=0.0]; ENSG00000125414, MYH2, myosin heavy chain 2, [RH, Score=2019, Expect=0.0]; ENSG00000109061, MYH1, myosin heavy chain 1, [RH, Score=2012, Expect=0.0]; ENSG00000133020, MYH8, myosin heavy chain 8, [RH, Score=2006, Expect=0.0]; ENSG00000264424, MYH4, myosin heavy chain 4, [RH, Score=1991, Expect=0.0]; ENSG00000109063, MYH3, myosin heavy chain 3, [RH, Score=1973, Expect=0.0]} {Mouse: ENSMUSG00000040752, Myh6, myosin, heavy polypeptide 6, cardiac muscle, alpha, [RH, Score=2073, Expect=0.0]; ENSMUSG00000053093, Myh7, myosin, heavy polypeptide 7, cardiac muscle, beta, [RH, Score=2063, Expect=0.0]; ENSMUSG00000057003, Myh4, myosin, heavy polypeptide 4, skeletal muscle, [RH, Score=2039, Expect=0.0]; ENSMUSG00000056328, Myh1, myosin, heavy polypeptide 1, skeletal muscle, adult, [RH, Score=2016, Expect=0.0]; ENSMUSG00000055775, Myh8, myosin, heavy polypeptide 8, skeletal muscle, perinatal, [RH, Score=2014, Expect=0.0]; ENSMUSG00000033196, Myh2, myosin, heavy polypeptide 2, skeletal muscle, adult, [RH, Score=2008, Expect=0.0]; ENSMUSG00000020908, Myh3, myosin, heavy polypeptide 3, skeletal muscle, embryonic, [RH, Score=1981, Expect=0.0]; ENSMUSG00000060180, Myh13, myosin, heavy polypeptide 13, skeletal muscle, [RH, Score=1978, Expect=0.0]} {Dmel: FBgn0264695, Mhc, Myosin heavy chain, [RH, Score=2100, Expect=0.0]} {Celegans: WBGene00019064, myo-5, MYOsin heavy chain structural genes, [RH, Score=1993, Expect=0.0]} {Smed: dd_Smed_v6_579_0_1, dd_Smed_v6_579_0_1, [RH, Score=2702, Expect=0.0]} {RNA1509_16048, RNA1509_42411} {RNA1310_1388, RNA1509_42411} {RNA1509_42411, RNA815_129.1} |
| 67. | MligTC455_53579 | 15576 | 324.49 | Mlig455_010515 | Neo: - Age: - Region-enriched R2: 1.446/0.00265 Regeneration-downregulated BL: -1.566 Regeneration-depleted BL: -1.566 |
1.782 | - | - | - | 0.819 | 0.963 | - | Mlig455_010515 {REF} {Length: 1448} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=80.3]} {Dmel: FBgn0041707, 7B2, [RH, Score=70.1, Expect=2e-13]} {Celegans: WBGene00011392, sbt-1, Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog, [RH, Score=67.4, Expect=5e-13]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [RH, Score=119, Expect=7e-32]} {RNA1509_1202, RNA1509_1348, RNA1509_17830} {RNA1310_24594, RNA1509_1202, RNA1509_1348, RNA1509_17830} {RNA1509_1202, RNA1509_1348, RNA1509_17830, RNA815_8289} | |
| 68. | MligTC455_23150 | 3195 | 66.56 | Mlig455_009524, Mlig455_009530 | Neo: - Age: - Region-enriched R2: 3.504/0.00000 |
CDK16 | 1.777 | - | - | - | 0.797 | 0.980 | - | Mlig455_009524 {REF} {Length: 3287} {Pfam: Protein kinase domain [PF00069.27, score=218.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.2]} {Human: ENSG00000102225, CDK16, cyclin dependent kinase 16, [RH, Score=463, Expect=7e-159]; ENSG00000059758, CDK17, cyclin dependent kinase 17, [RH, Score=447, Expect=2e-151]} {Mouse: ENSMUSG00000031065, Cdk16, cyclin-dependent kinase 16, [RH, Score=464, Expect=2e-158]; ENSMUSG00000020015, Cdk17, cyclin-dependent kinase 17, [RH, Score=449, Expect=2e-152]} {Dmel: FBgn0005640, Eip63E, Ecdysone-induced protein 63E, [Score=362, Expect=2e-118]} {Celegans: WBGene00003961, pct-1, Cyclin-dependent kinase 17, [RH, Score=417, Expect=3e-138]} {Smed: dd_Smed_v6_4172_0_4, dd_Smed_v6_4172_0_4, [RH, Score=449, Expect=6e-151]} {RNA1509_23462} {RNA1310_21506} {RNA815_9702} Mlig455_009530 {REF} {Length: 3384} {Pfam: Protein kinase domain [PF00069.27, score=208.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.4]; Haspin like kinase domain [PF12330.10, score=17.8]} {Human: ENSG00000102225, CDK16, cyclin dependent kinase 16, [Score=432, Expect=5e-147]} {Mouse: ENSMUSG00000031065, Cdk16, cyclin-dependent kinase 16, [Score=431, Expect=4e-146]} {Dmel: FBgn0005640, Eip63E, Ecdysone-induced protein 63E, [Score=329, Expect=9e-107]} {Celegans: WBGene00003961, pct-1, Cyclin-dependent kinase 17, [Score=392, Expect=2e-130]} {Smed: dd_Smed_v6_4172_0_4, dd_Smed_v6_4172_0_4, [Score=411, Expect=6e-137]} {RNA1509_23462} {RNA1310_21506} {RNA815_9702} |
| 69. | MligTC455_20686 | 474 | 9.88 | Mlig455_041407, Mlig455_041444, Mlig455_060901 | Neo: - Age: - Region-enriched R2: 1.932/0.02120 |
1.775 | - | 0.824 | - | - | 0.951 | - | Mlig455_041407 {REF} {Length: 1387} {Smed: dd_Smed_v6_12479_0_1, dd_Smed_v6_12479_0_1, [RH, Score=73.6, Expect=3e-17]} {RNA1509_36978} {RNA1310_41260} {RNA815_26996} Mlig455_041444 {REF} {Length: 935} {Smed: dd_Smed_v6_12479_0_1, dd_Smed_v6_12479_0_1, [RH, Score=73.6, Expect=4e-17]} {RNA1509_36978} {RNA1310_41260} {RNA815_47140} Mlig455_060901 {REF} {Length: 2316} {Smed: dd_Smed_v6_12479_0_1, dd_Smed_v6_12479_0_1, [RH, Score=73.6, Expect=3e-17]} {RNA1509_36978} {RNA1310_41260} {RNA815_47140} |
|
| 70. | MligTC455_18097 | 35 | 0.72 | Mlig455_009236 | Neo: - Age: Down-Down-Down Region-enriched R2: 6.206/0.03997 |
CUBN | 1.771 | - | - | - | 0.807 | 0.964 | - | Mlig455_009236 {REF} {Length: 3722} {Human: ENSG00000107611, CUBN, cubilin, [Score=60.1, Expect=9e-09]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=65.5, Expect=1e-10]} {Dmel: FBgn0261262, CG42613, [Score=145, Expect=2e-36]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=120, Expect=2e-28]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=228, Expect=8e-65]} {RNA1509_40917} {RNA1310_5203.2, RNA1509_40917} {RNA1509_40917, RNA815_10358} |
| 71. | MligTC455_23977 | 63 | 1.31 | Mlig455_012689 | Neo: - Age: - Regeneration-downregulated R5: -6.245 Regeneration-depleted R5: -6.245 |
DRD2 | 1.771 | - | - | - | 0.813 | 0.958 | - | Mlig455_012689 {REF} {Length: 2124} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=191.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=32.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.4]} {Human: ENSG00000149295, DRD2, dopamine receptor D2, [Score=170, Expect=1e-46]} {Mouse: ENSMUSG00000032259, Drd2, dopamine receptor D2, [Score=168, Expect=4e-46]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [RH, Score=160, Expect=4e-43]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=159, Expect=2e-42]} {Smed: dd_Smed_v6_27884_0_1, dd_Smed_v6_27884_0_1, [Score=198, Expect=7e-57]} {RNA1310_28840} {RNA815_30584} |
| 72. | MligTC455_53580 | 10830 | 225.63 | Mlig455_061858 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.371 Region-specific R2: 2.295 Region-enriched R2: 1.602/0.00040 Regeneration-downregulated BL: -1.692 Regeneration-depleted BL: -1.692 |
1.764 | - | - | - | 0.806 | 0.958 | - | Mlig455_061858 {REF} {Length: 1839} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=32.7]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [Score=77.4, Expect=9e-17]} {RNA1509_2808} {RNA1310_24594} {RNA815_8289} | |
| 73. | MligTC455_53581 | 10826 | 225.54 | Mlig455_061865 | Neo: - Age: Down-Down-Up Region-specific R2: 2.296 Region-enriched R2: 1.603/0.00040 Regeneration-downregulated BL: -1.690 Regeneration-depleted BL: -1.690 |
1.764 | - | - | - | 0.806 | 0.958 | - | Mlig455_061865 {REF} {Length: 1605} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=82.0]} {Dmel: FBgn0041707, 7B2, [RH, Score=70.1, Expect=1e-13]} {Celegans: WBGene00011392, sbt-1, Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog, [RH, Score=67.4, Expect=4e-13]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [RH, Score=118, Expect=1e-31]} {RNA1509_1202, RNA1509_24767} {RNA1310_24594, RNA1509_24767} {RNA1509_24767, RNA815_8289} | |
| 74. | MligTC455_48006 | 701 | 14.61 | Mlig455_007273, Mlig455_031838, Mlig455_068306 | Neo: - Age: - Region-specific R2: 2.969 Region-enriched R2: 2.942/0.00000 |
DAG1 | 1.76 | - | 0.805 | - | - | 0.955 | - | Mlig455_007273 {REF} {Length: 4574} {Pfam: Dystroglycan (Dystrophin-associated glycoprotein 1) [PF05454.13, score=33.4]; Alpha-Dystroglycan N-terminal domain 2 [PF18424.3, score=23.0]; TMEM154 protein family [PF15102.8, score=20.3]} {Smed: dd_Smed_v6_11814_0_1, dd_Smed_v6_11814_0_1, [Score=75.5, Expect=2e-13]} {RNA1509_12492} {RNA1310_1589.1} {RNA815_11235} Mlig455_031838 {REF} {Length: 4722} {TRANSSPLICED} {Pfam: Dystroglycan (Dystrophin-associated glycoprotein 1) [PF05454.13, score=33.3]; Alpha-Dystroglycan N-terminal domain 2 [PF18424.3, score=32.4]; TMEM154 protein family [PF15102.8, score=20.2]} {Human: ENSG00000173402, DAG1, dystroglycan 1, [Score=58.9, Expect=6e-08]} {Mouse: ENSMUSG00000039952, Dag1, dystroglycan 1, [Score=57.8, Expect=9e-08]} {Smed: dd_Smed_v6_11814_0_1, dd_Smed_v6_11814_0_1, [Score=95.9, Expect=1e-19]} {RNA1509_12492} {RNA1310_1589.1} {RNA815_11235} Mlig455_068306 {REF} {Length: 4731} {TRANSSPLICED} {Pfam: Dystroglycan (Dystrophin-associated glycoprotein 1) [PF05454.13, score=33.3]; Alpha-Dystroglycan N-terminal domain 2 [PF18424.3, score=32.4]; TMEM154 protein family [PF15102.8, score=20.2]} {Human: ENSG00000173402, DAG1, dystroglycan 1, [Score=58.5, Expect=7e-08]} {Mouse: ENSMUSG00000039952, Dag1, dystroglycan 1, [Score=57.4, Expect=1e-07]} {Smed: dd_Smed_v6_11814_0_1, dd_Smed_v6_11814_0_1, [Score=97.8, Expect=2e-20]} {RNA1509_12492} {RNA1310_1589.1, RNA1509_12492} {RNA1509_12492, RNA815_11235} |
| 75. | MligTC455_53382 | 110 | 2.28 | Mlig455_006777 | Neo: - Age: - |
1.756 | - | - | - | 0.792 | 0.964 | - | Mlig455_006777 {REF} {Length: 2841} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.8]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=48.9, Expect=1e-05]} {Smed: dd_Smed_v6_8885_0_1, dd_Smed_v6_8885_0_1, [Score=137, Expect=6e-36]} {RNA1509_47534} {RNA1310_15311} {RNA815_12841} | |
| 76. | MligTC455_44094 | 90 | 1.88 | Mlig455_018759 | Neo: - Age: - |
PCDH17 | 1.753 | - | - | - | 0.780 | 0.973 | - | Mlig455_018759 {REF} {Length: 3612} {Pfam: Cadherin domain [PF00028.19, score=240.7]; Cadherin-like [PF16184.7, score=28.6]; Cadherin-like [PF08266.14, score=27.8]} {Human: ENSG00000118946, PCDH17, protocadherin 17, [RH, Score=263, Expect=1e-73]} {Mouse: ENSMUSG00000035566, Pcdh17, protocadherin 17, [RH, Score=264, Expect=7e-73]; ENSMUSG00000051323, Pcdh19, protocadherin 19, [RH, Score=261, Expect=6e-72]; ENSMUSG00000104063, Pcdhgb7, protocadherin gamma subfamily B, 7, [RH, Score=260, Expect=2e-72]} {Dmel: FBgn0024836, stan, starry night, [Score=215, Expect=1e-56]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=176, Expect=2e-44]} {Smed: dd_Smed_v6_21489_0_1, dd_Smed_v6_21489_0_1, [Score=283, Expect=5e-81]} {RNA1509_38737} {RNA1310_26793, RNA1509_38737} {RNA1509_38737, RNA815_46826} |
| 77. | MligTC455_40559 | 119 | 2.48 | Mlig455_063539 | Neo: - Age: - |
FO681492.1 | 1.752 | - | - | - | 0.801 | 0.951 | - | Mlig455_063539 {REF} {Length: 2231} {Pfam: C2 domain [PF00168.32, score=40.3]} {Human: ENSG00000277758, FO681492.1, synaptotagmin-15, [Score=74.3, Expect=1e-13]; ENSG00000204176, SYT15, synaptotagmin 15, [Score=73.9, Expect=1e-13]} {Mouse: ENSMUSG00000041479, Syt15, synaptotagmin XV, [Score=65.5, Expect=6e-11]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=52.4, Expect=4e-07]} {RNA1310_23463.1} {RNA815_43860} |
| 78. | MligTC455_33707 | 211 | 4.4 | Mlig455_018361 | Neo: - Age: - |
XRRA1 | 1.745 | - | - | - | 0.792 | 0.953 | - | Mlig455_018361 {REF} {Length: 3845} {Pfam: Leucine Rich repeats (2 copies) [PF12799.9, score=41.5]; Leucine rich repeat [PF13855.8, score=28.9]} {Human: ENSG00000166435, XRRA1, X-ray radiation resistance associated 1, [RH, Score=167, Expect=1e-45]} {Mouse: ENSMUSG00000035211, Xrra1, X-ray radiation resistance associated 1, [RH, Score=171, Expect=1e-43]} {Celegans: WBGene00006820, unc-89, Muscle M-line assembly protein unc-89, [Score=63.9, Expect=7e-10]} {Smed: dd_Smed_v6_13519_0_1, dd_Smed_v6_13519_0_1, [RH, Score=154, Expect=3e-38]} {RNA1509_45583} {RNA1310_16743.1} {RNA815_17679} |
| 79. | MligTC455_33552 | 905 | 18.86 | Mlig455_014406, Mlig455_070160 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.705/0.03873 |
KCNH1 | 1.734 | - | - | 0.776 | - | 0.958 | - | Mlig455_014406 {REF} {Length: 5774} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=54.1]} {Human: ENSG00000143473, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=269, Expect=1e-82]; ENSG00000283965, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=269, Expect=1e-82]; ENSG00000140015, KCNH5, potassium voltage-gated channel subfamily H member 5, [Score=256, Expect=1e-74]} {Mouse: ENSMUSG00000058248, Kcnh1, potassium voltage-gated channel, subfamily H (eag-related), member 1, [Score=267, Expect=4e-79]; ENSMUSG00000034402, Kcnh5, potassium voltage-gated channel, subfamily H (eag-related), member 5, [Score=256, Expect=3e-75]} {Dmel: FBgn0000535, eag, ether a go-go, [Score=283, Expect=5e-84]} {Celegans: WBGene00001171, egl-2, EAG K+ channel EGL-2, [Score=240, Expect=1e-69]} {Smed: dd_Smed_v6_23063_0_1, dd_Smed_v6_23063_0_1, [Score=283, Expect=7e-86]} {RNA1509_16580} {RNA1310_9615} {RNA815_20522} Mlig455_070160 {REF} {Length: 3641} {Pfam: Ion transport protein [PF00520.33, score=111.5]; Cyclic nucleotide-binding domain [PF00027.31, score=53.3]; Ion channel [PF07885.18, score=40.6]} {Human: ENSG00000143473, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=795, Expect=0.0]; ENSG00000283965, KCNH1, potassium voltage-gated channel subfamily H member 1, [Score=795, Expect=0.0]; ENSG00000140015, KCNH5, potassium voltage-gated channel subfamily H member 5, [Score=771, Expect=0.0]} {Mouse: ENSMUSG00000058248, Kcnh1, potassium voltage-gated channel, subfamily H (eag-related), member 1, [Score=794, Expect=0.0]; ENSMUSG00000034402, Kcnh5, potassium voltage-gated channel, subfamily H (eag-related), member 5, [Score=770, Expect=0.0]} {Dmel: FBgn0000535, eag, ether a go-go, [Score=838, Expect=0.0]} {Celegans: WBGene00001171, egl-2, EAG K+ channel EGL-2, [Score=688, Expect=0.0]} {Smed: dd_Smed_v6_18793_0_1, dd_Smed_v6_18793_0_1, [Score=895, Expect=0.0]} {RNA1509_16580} {RNA1310_6070} {RNA815_18231} |
| 80. | MligTC455_34925 | 183 | 3.82 | Mlig455_012715 | Neo: - Age: - |
CDKL1 | 1.73 | - | - | - | 0.780 | 0.950 | - | Mlig455_012715 {REF} {Length: 2370} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=250.2]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=120.6]; RIO1 family [PF01163.24, score=23.0]; ABC1 atypical kinase-like domain [PF03109.18, score=20.8]; Haspin like kinase domain [PF12330.10, score=20.4]; Kinase-like [PF14531.8, score=19.4]} {Human: ENSG00000100490, CDKL1, cyclin dependent kinase like 1, [RH, Score=437, Expect=3e-153]; ENSG00000205111, CDKL4, cyclin dependent kinase like 4, [RH, Score=424, Expect=2e-147]} {Mouse: ENSMUSG00000020990, Cdkl1, cyclin-dependent kinase-like 1 (CDC2-related kinase), [RH, Score=437, Expect=2e-153]; ENSMUSG00000033966, Cdkl4, cyclin-dependent kinase-like 4, [RH, Score=432, Expect=2e-151]} {Dmel: FBgn0031730, CG7236, [RH, Score=384, Expect=3e-131]} {Celegans: WBGene00012779, cdkl-1, Cyclin-Dependent Kinase-Like, [RH, Score=388, Expect=3e-132]} {Smed: dd_Smed_v6_9353_0_1, dd_Smed_v6_9353_0_1, [RH, Score=472, Expect=5e-167]} {RNA1509_44617} {RNA1310_15038, RNA1509_44617} {RNA1509_44617, RNA815_6379} |
| 81. | MligTC455_47601 | 126 | 2.62 | Mlig455_056477 | Neo: - Age: Up-Down-Up |
NRXN1 | 1.729 | - | 0.761 | - | - | 0.968 | - | Mlig455_056477 {REF} {Length: 3481} {Pfam: Laminin G domain [PF02210.26, score=58.3]; Laminin G domain [PF00054.25, score=43.2]; Syndecan domain [PF01034.22, score=27.4]} {Human: ENSG00000179915, NRXN1, neurexin 1, [Score=142, Expect=4e-35]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=142, Expect=1e-35]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=102, Expect=2e-22]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [Score=142, Expect=8e-36]} {RNA1509_55888} {RNA1310_37025, RNA1509_55888} {RNA1509_55888, RNA815_22404} |
| 82. | MligTC455_37315 | 84 | 1.76 | Mlig455_048842 | Neo: - Age: - |
CALM2 | 1.728 | - | - | - | 0.746 | 0.982 | - | Mlig455_048842 {REF} {Length: 1287} {Pfam: EF-hand domain pair [PF13499.8, score=22.7]; EF-hand domain [PF14658.8, score=19.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=68.9, Expect=6e-14]; ENSG00000198668, CALM1, calmodulin 1, [Score=68.2, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=66.6, Expect=2e-13]; ENSG00000178363, CALML3, calmodulin like 3, [Score=65.5, Expect=4e-13]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=2e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=66.6, Expect=1e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=66.6, Expect=1e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=68.6, Expect=1e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=68.6, Expect=1e-14]} {Smed: dd_Smed_v6_5491_0_1, dd_Smed_v6_5491_0_1, [Score=110, Expect=3e-30]} {RNA1310_33365} {RNA815_27013} |
| 83. | MligTC455_46173 | 63 | 1.3 | Mlig455_032091 | Neo: Irradiation Age: Up-Down-Up |
SRR | 1.726 | - | - | - | 0.741 | 0.985 | - | Mlig455_032091 {REF} {Length: 2590} {Pfam: Pyridoxal-phosphate dependent enzyme [PF00291.27, score=208.5]; ACT domain [PF01842.27, score=19.8]} {Human: ENSG00000167720, SRR, serine racemase, [Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000001323, Srr, serine racemase, [Score=105, Expect=4e-24]} {Dmel: FBgn0037684, CG8129, [Score=373, Expect=5e-123]} {Celegans: WBGene00010456, K01C8.1, [Score=407, Expect=5e-136]} {Smed: dd_Smed_v6_6737_0_1, dd_Smed_v6_6737_0_1, [Score=474, Expect=7e-163]} {RNA1509_48789} {RNA1310_15074} {RNA815_9364} |
| 84. | MligTC455_17383 | 1327 | 27.64 | Mlig455_022114, Mlig455_053650 | Neo: - Age: - |
1.723 | - | - | - | - | 0.956 | 0.767 | Mlig455_022114 {REF} {Length: 3990} {Pfam: Domain of Unknown Function (DUF1542) [PF07564.13, score=21.5]} {RNA1509_4411} {RNA1310_4537.1, RNA1509_4411} {RNA1509_4411, RNA815_1371} Mlig455_053650 {REF} {Length: 4005} {Pfam: Domain of Unknown Function (DUF1542) [PF07564.13, score=21.5]} {RNA1509_4411, RNA1509_52435} {RNA1310_4537.1, RNA1509_52435} {RNA1509_52435, RNA815_1371} |
|
| 85. | MligTC455_35505 | 126 | 2.62 | Mlig455_018997, Mlig455_022533, Mlig455_055707 | Neo: - Age: - |
HRH2, SYT7 | 1.723 | - | 0.762 | - | - | 0.961 | - | Mlig455_018997 {REF} {Length: 4854} {Pfam: C2 domain [PF00168.32, score=156.5]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=271, Expect=9e-84]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=261, Expect=3e-81]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [RH, Score=243, Expect=4e-76]} {Celegans: WBGene00004926, snt-6, SyNapTotagmin, [RH, Score=182, Expect=1e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=199, Expect=6e-60]} {RNA1310_29722} {RNA815_16467} Mlig455_022533 {REF} {Length: 1223} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=80.1]} {Human: ENSG00000113749, HRH2, histamine receptor H2, [Score=68.6, Expect=4e-12]} {Mouse: ENSMUSG00000044338, Aplnr, apelin receptor, [Score=64.3, Expect=7e-11]; ENSMUSG00000037424, Taar9, trace amine-associated receptor 9, [Score=63.9, Expect=9e-11]; ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=63.2, Expect=2e-10]} {Dmel: FBgn0039595, AstA-R2, Allatostatin A receptor 2, [Score=53.1, Expect=2e-07]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [Score=63.2, Expect=9e-11]} Mlig455_055707 {REF} {Length: 2803} {Pfam: C2 domain [PF00168.32, score=156.6]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=270, Expect=2e-83]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=259, Expect=4e-81]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [RH, Score=243, Expect=2e-76]} {Celegans: WBGene00004926, snt-6, SyNapTotagmin, [RH, Score=182, Expect=1e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=199, Expect=4e-60]} {RNA1310_29722} {RNA815_16467} |
| 86. | MligTC455_46340 | 259 | 5.4 | Mlig455_049774 | Neo: - Age: - Region-enriched R1: 5.320/0.00375 |
1.721 | - | - | - | 0.754 | 0.967 | - | Mlig455_049774 {REF} {Length: 1638} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=40.1]; Ankyrin repeats (many copies) [PF13637.8, score=27.8]; Ankyrin repeats (many copies) [PF13857.8, score=24.8]; Ankyrin repeat [PF13606.8, score=19.1]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [RH, Score=75.9, Expect=1e-14]} {RNA1509_39973} {RNA1310_21889} {RNA815_13094} | |
| 87. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
1.719 | - | - | 0.743 | - | 0.976 | - | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
| 88. | MligTC455_20332 | 34 | 0.71 | Mlig455_038515 | Neo: - Age: - |
1.717 | - | - | - | 0.757 | 0.960 | - | Mlig455_038515 {REF} {Length: 2092} {RNA1509_52468} {RNA1310_41235} {RNA815_11414.1} | |
| 89. | MligTC455_29118 | 467 | 9.72 | Mlig455_040411 | Neo: - Age: - Region-specific R2: 6.456 Region-enriched R2: 5.344/0.00023 |
1.717 | - | - | 0.752 | - | 0.965 | - | Mlig455_040411 {REF} {Length: 599} {TRANSSPLICED} {RNA1509_53840} {RNA1310_67192, RNA1509_53840} {RNA1509_53840, RNA815_27042} | |
| 90. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 1.713 | - | - | 0.730 | - | 0.983 | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
| 91. | MligTC455_19298 | 52 | 1.08 | Mlig455_007404 | Neo: - Age: - |
IRX4 | 1.704 | - | - | - | - | 0.980 | 0.724 | Mlig455_007404 {REF} {Length: 1775} {Pfam: Homeobox KN domain [PF05920.13, score=53.9]; Homeodomain [PF00046.31, score=30.1]} {Human: ENSG00000113430, IRX4, iroquois homeobox 4, [RH, Score=149, Expect=2e-39]; ENSG00000159387, IRX6, iroquois homeobox 6, [RH, Score=147, Expect=6e-39]} {Mouse: ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [RH, Score=150, Expect=5e-40]; ENSMUSG00000031738, Irx6, Iroquois homeobox 6, [RH, Score=145, Expect=1e-38]} {Dmel: FBgn0015919, caup, caupolican, [RH, Score=153, Expect=3e-40]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [RH, Score=124, Expect=1e-31]} {Smed: dd_Smed_v6_17352_0_1, dd_Smed_v6_17352_0_1, [RH, Score=159, Expect=3e-44]} {RNA1310_58105} {RNA815_61910} |
| 92. | MligTC455_22356 | 28 | 0.57 | Mlig455_009532 | Neo: - Age: - Region-enriched R5: 4.548/0.03532 |
GALR2 | 1.699 | - | - | 0.746 | - | 0.953 | - | Mlig455_009532 {REF} {Length: 3801} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=72.4]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=50.8, Expect=6e-06]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=52.4, Expect=1e-06]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=50.1, Expect=3e-06]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [Score=126, Expect=3e-31]} {RNA1310_79397} {RNA815_39017} |
| 93. | MligTC455_53307 | 32 | 0.67 | Mlig455_018445 | Neo: - Age: Up-Down-Down |
SLC4A11 | 1.697 | - | - | - | 0.746 | 0.951 | - | Mlig455_018445 {REF} {Length: 3675} {Pfam: HCO3- transporter family [PF00955.23, score=519.3]; Band 3 cytoplasmic domain [PF07565.15, score=37.0]; Phosphoenolpyruvate-dependent sugar phosphotransferase system, EIIA 2 [PF00359.24, score=23.1]} {Human: ENSG00000088836, SLC4A11, solute carrier family 4 member 11, [RH, Score=536, Expect=2e-175]} {Mouse: ENSMUSG00000074796, Slc4a11, solute carrier family 4, sodium bicarbonate transporter-like, member 11, [RH, Score=529, Expect=9e-174]} {Dmel: FBgn0036043, CG8177, [Score=256, Expect=1e-70]} {Celegans: WBGene00019018, abts-3, Anion transporter ABTS-3; Anion/Bicarbonate TranSporter family, [RH, Score=690, Expect=0.0]} {Smed: dd_Smed_v6_12290_0_1, dd_Smed_v6_12290_0_1, [RH, Score=929, Expect=0.0]} {RNA1509_57265} {RNA1310_5995, RNA1509_57265} {RNA1509_57265, RNA815_19456} |
| 94. | MligTC455_14684 | 7049 | 146.85 | Mlig455_051414 | Neo: - Age: - Region-specific R2: 2.287 Region-enriched R2: 1.764/0.00001 Regeneration-depleted BL: -2.197 |
PAM | 1.688 | - | - | - | - | 0.952 | 0.736 | Mlig455_051414 {REF} {Length: 1674} {TRANSSPLICED} {Pfam: NHL repeat [PF01436.23, score=89.1]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=194, Expect=4e-55]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [RH, Score=206, Expect=4e-62]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [RH, Score=206, Expect=3e-63]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [RH, Score=249, Expect=2e-79]} {RNA1509_910} {RNA1310_18216.1, RNA1509_910} {RNA1509_910, RNA815_736.1} |
| 95. | MligTC455_11473 | 248 | 5.17 | Mlig455_009711, Mlig455_071036 | Neo: - Age: Down-Up-Down |
CHRNA3 | 1.685 | - | - | 0.714 | - | 0.971 | - | Mlig455_009711 {REF} {Length: 2402} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=241.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=391, Expect=2e-130]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=379, Expect=6e-126]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=375, Expect=2e-124]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=390, Expect=2e-130]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=375, Expect=2e-124]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [RH, Score=499, Expect=9e-173]} {Celegans: WBGene00000043, acr-3, Acetylcholine receptor subunit beta-type acr-3, [RH, Score=426, Expect=6e-145]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=510, Expect=1e-176]} {RNA1509_48201} {RNA1310_10118} {RNA815_29940} Mlig455_071036 {REF} {Length: 746} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.1]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=63.5, Expect=2e-13]} {Celegans: WBGene00000042, acr-2, Acetylcholine receptor subunit beta-type acr-2, [Score=63.9, Expect=9e-14]} {Smed: dd_Smed_v6_12535_0_1, dd_Smed_v6_12535_0_1, [Score=64.3, Expect=6e-14]} {RNA1310_21182} {RNA815_29940} |
| 96. | MligTC455_41226 | 44 | 0.92 | Mlig455_019357, Mlig455_059122 | Neo: - Age: - |
GALNT1 | 1.683 | - | - | 0.719 | - | 0.964 | - | Mlig455_019357 {REF} {Length: 1606} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=97.5]; Glycosyltransferase like family 2 [PF13641.8, score=38.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.1]; Glycosyltransferase like family 2 [PF10111.11, score=18.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=318, Expect=2e-103]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=311, Expect=4e-100]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=305, Expect=3e-98]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=305, Expect=3e-98]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=316, Expect=1e-102]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=308, Expect=9e-99]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=302, Expect=3e-97]} {Dmel: FBgn0050463, CG30463, [Score=345, Expect=5e-113]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=350, Expect=3e-115]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=353, Expect=1e-117]} {RNA1310_25598} {RNA815_36943} Mlig455_059122 {REF} {Length: 2150} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=96.4]; Glycosyltransferase like family 2 [PF13641.8, score=35.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=313, Expect=2e-101]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=307, Expect=2e-98]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=300, Expect=6e-96]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=299, Expect=7e-96]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=1e-95]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=311, Expect=1e-100]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=305, Expect=1e-97]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=8e-96]; ENSMUSG00000026994, Galnt3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=296, Expect=5e-94]; ENSMUSG00000026828, Galnt5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=296, Expect=2e-91]} {Dmel: FBgn0050463, CG30463, [Score=340, Expect=3e-111]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=344, Expect=3e-113]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=350, Expect=3e-116]} {RNA1310_25598} {RNA815_36943} |
| 97. | MligTC455_43509 | 1526 | 31.78 | Mlig455_024779, Mlig455_066104, Mlig455_068669 | Neo: - Age: Down-Up-Up |
ACSL1 | 1.678 | - | - | - | - | 0.951 | 0.727 | Mlig455_024779 {REF} {Length: 2596} {Pfam: AMP-binding enzyme [PF00501.30, score=343.5]; AMP-binding enzyme C-terminal domain [PF13193.8, score=23.4]} {Human: ENSG00000151726, ACSL1, acyl-CoA synthetase long chain family member 1, [Score=534, Expect=0.0]; ENSG00000164398, ACSL6, acyl-CoA synthetase long chain family member 6, [Score=518, Expect=1e-175]; ENSG00000197142, ACSL5, acyl-CoA synthetase long chain family member 5, [Score=514, Expect=2e-174]} {Mouse: ENSMUSG00000018796, Acsl1, acyl-CoA synthetase long-chain family member 1, [Score=515, Expect=9e-175]; ENSMUSG00000024981, Acsl5, acyl-CoA synthetase long-chain family member 5, [Score=513, Expect=6e-174]; ENSMUSG00000020333, Acsl6, acyl-CoA synthetase long-chain family member 6, [Score=509, Expect=3e-172]} {Dmel: FBgn0036821, CG3961, [RH, Score=552, Expect=0.0]} {Celegans: WBGene00013575, acs-5, Fatty Acid CoA Synthetase family, [Score=476, Expect=4e-160]} {Smed: dd_Smed_v6_2009_0_2, dd_Smed_v6_2009_0_2, [Score=427, Expect=5e-141]} {RNA1509_51374} {RNA1310_7356.1} {RNA815_5550.1} Mlig455_066104 {REF} {Length: 2816} {Pfam: AMP-binding enzyme [PF00501.30, score=343.8]; AMP-binding enzyme C-terminal domain [PF13193.8, score=23.5]} {Human: ENSG00000151726, ACSL1, acyl-CoA synthetase long chain family member 1, [Score=531, Expect=1e-180]; ENSG00000197142, ACSL5, acyl-CoA synthetase long chain family member 5, [Score=516, Expect=3e-175]; ENSG00000164398, ACSL6, acyl-CoA synthetase long chain family member 6, [Score=513, Expect=1e-173]} {Mouse: ENSMUSG00000018796, Acsl1, acyl-CoA synthetase long-chain family member 1, [Score=512, Expect=2e-173]; ENSMUSG00000024981, Acsl5, acyl-CoA synthetase long-chain family member 5, [Score=511, Expect=4e-173]; ENSMUSG00000020333, Acsl6, acyl-CoA synthetase long-chain family member 6, [Score=506, Expect=5e-171]} {Dmel: FBgn0036821, CG3961, [RH, Score=551, Expect=0.0]} {Celegans: WBGene00013575, acs-5, Fatty Acid CoA Synthetase family, [Score=476, Expect=6e-160]} {Smed: dd_Smed_v6_2009_0_2, dd_Smed_v6_2009_0_2, [Score=424, Expect=7e-140]} {RNA1509_21029, RNA1509_51374} {RNA1310_7356.1, RNA1509_21029, RNA1509_51374} {RNA1509_21029, RNA1509_51374, RNA815_5550.1} Mlig455_068669 {REF} {Length: 2627} {Pfam: AMP-binding enzyme [PF00501.30, score=343.5]; AMP-binding enzyme C-terminal domain [PF13193.8, score=23.4]} {Human: ENSG00000151726, ACSL1, acyl-CoA synthetase long chain family member 1, [Score=534, Expect=0.0]; ENSG00000164398, ACSL6, acyl-CoA synthetase long chain family member 6, [Score=518, Expect=1e-175]; ENSG00000197142, ACSL5, acyl-CoA synthetase long chain family member 5, [Score=514, Expect=2e-174]} {Mouse: ENSMUSG00000018796, Acsl1, acyl-CoA synthetase long-chain family member 1, [Score=515, Expect=9e-175]; ENSMUSG00000024981, Acsl5, acyl-CoA synthetase long-chain family member 5, [Score=513, Expect=6e-174]; ENSMUSG00000020333, Acsl6, acyl-CoA synthetase long-chain family member 6, [Score=509, Expect=3e-172]} {Dmel: FBgn0036821, CG3961, [RH, Score=552, Expect=0.0]} {Celegans: WBGene00013575, acs-5, Fatty Acid CoA Synthetase family, [Score=476, Expect=4e-160]} {Smed: dd_Smed_v6_2009_0_2, dd_Smed_v6_2009_0_2, [Score=427, Expect=5e-141]} {RNA1509_51374} {RNA1310_7356.1} {RNA815_5550.1} |
| 98. | MligTC455_20366 | 315 | 6.57 | Mlig455_016461, Mlig455_016527, Mlig455_049812 | Neo: - Age: - |
1.675 | - | - | 0.711 | 0.964 | - | - | Mlig455_016461 {REF} {Length: 3503} {RNA1509_38265} {RNA1310_8609} {RNA815_9870} Mlig455_016527 {REF} {Length: 3465} {RNA1509_38265} {RNA1310_8609} {RNA815_9870} Mlig455_049812 {REF} {Length: 3193} {RNA1509_38265} {RNA1310_8609} {RNA815_9870} |
|
| 99. | MligTC455_24140 | 233 | 4.85 | Mlig455_025664 | Neo: - Age: logFC(26M/2M)=-0.253 |
TTLL5 | 1.672 | - | - | - | - | 0.956 | 0.716 | Mlig455_025664 {REF} {Length: 4813} {TRANSSPLICED} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=295.9]; YheC/D like ATP-grasp [PF14398.8, score=27.5]; Sugar-transfer associated ATP-grasp [PF14397.8, score=20.8]} {Human: ENSG00000119685, TTLL5, tubulin tyrosine ligase like 5, [Score=313, Expect=2e-98]} {Mouse: ENSMUSG00000012609, Ttll5, tubulin tyrosine ligase-like family, member 5, [Score=591, Expect=0.0]} {Dmel: FBgn0051108, CG31108, [RH, Score=454, Expect=1e-143]} {Celegans: WBGene00008331, ttll-5, Tubulin Tyrosine Ligase Like, [RH, Score=328, Expect=5e-99]} {Smed: dd_Smed_v6_6390_0_1, dd_Smed_v6_6390_0_1, [RH, Score=715, Expect=0.0]} {RNA1509_15780, RNA1509_40594} {RNA1310_2679, RNA1509_15780, RNA1509_40594} {RNA1509_15780, RNA1509_40594, RNA815_6621} |
| 100. | MligTC455_17197 | 170 | 3.54 | Mlig455_053652 | Neo: - Age: - |
1.668 | - | - | 0.703 | - | 0.965 | - | Mlig455_053652 {REF} {Length: 2429} {TRANSSPLICED} {RNA1509_44480} {RNA1310_34935, RNA1509_44480} {RNA1509_44480, RNA815_20343} |
There are 50 more genes with r >= 0.95